Estimation of the minimum effective volume of 0.5% Levobupivacaine in ultrasound guided supraclavicular brachial block in patients undergoing upper limb orthopaedic surgeries.

Study to determine the minimum effective volume of 0.5% Levobupivacaine in ultrasound guided supraclavicular brachial plexus block in patients undergoing upper limb orthopaedic surgeries- A prospective clinical trial.

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/045005

Enrollment

Registered

2022-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Levobupivacaine for supraclavicular brachial plexus block: 0.5% Levobupivacaine single injection Intervention2: Vvv: Vvv Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-60 years and 2. Belonging to ASA physical status 1 or 2 and 3. Scheduled for forearm orthopaedic surgeries

Exclusion criteria

Exclusion criteria: 1. Refusal of consent 2. Allergy to local anaesthetic 3. Pregnancy 4. Bleeding diathesis or coagulopathy 5. Contraindications absolute and relative to supraclavicular block

Design outcomes

Primary

Measure	Time frame
To determine Minimum Effective Volume of 0.5% Levobupivacaine in ultrasound guided supraclavicular brachial plexus block to achieve readiness for surgery in patients undergoing forearm orthopaedic surgeries Timepoint: Assessment will be done immediately after complete injection of drug Baseline	—

Secondary

Measure	Time frame
Duration of motor blockadeTimepoint: Baseline to 8 hours after injection of drug;Duration of post operative analgesia Timepoint: 4 6 and 8 hours after surgery;Mean time for onset of sensory and motor blockade Timepoint: Baseline to 30 minutes after injection of drug	—

Countries

India

Contacts

Public ContactDr Eesha Eva Devaiah

Shimoga Institute of Medical Sciences

eeshadevaiah@gmail.com9740470980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026